The Scandinavian Propaten® Trial - 1-Year patency of PTFE vascular prostheses with heparin-bonded luminal surfaces compared to ordinary pure PTFE vascular prostheses - A randomised clinical controlled multi-centre trial

European Journal of Vascular and Endovascular Surgery

Volumn 41, Issue 5, 2011, Pages 668-673

  Lindholt, J S ^a   Gottschalksen, B ^b   Johannesen, N ^c   Dueholm, D ^d   Ravn, H ^e   Christensen, E D ^f   Viddal, B ^g   Florenes T ^h   Pedersen, G ⁱ   Rasmussen, M ^j   Carstensen, M ^k   Grondal N ^a   Fasting, H ^a  

^a VIBORG HOSPITAL   (Denmark)

^b SLAGELSE HOSPITAL   (Denmark)

^c AALBORG UNIVERSITY HOSPITAL   (Denmark)

^d KOLDING HOSPITAL   (Denmark)

^e Eksjo Hospital   (Sweden)

^f Aabenraa Hospital   (Denmark)

^g STAVANGER UNIVERSITY HOSPITAL   (Norway)

^h AKER UNIVERSITY HOSPITAL   (Norway)

ⁱ HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^j GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^k Rigshospitalet   (Denmark)

more..

Author keywords

Bypass; Femoropopliteal; Grafts; Patency; Peripheral arterial disease; PFTE

Indexed keywords

HEPARIN;

ADULT; AGED; ARTICLE; BLEEDING; BLOOD VESSEL PROSTHESIS; DOUBLE BLIND PROCEDURE; ECHOGRAPHY; FEMALE; FEMOROFEMORAL BYPASS; FEMOROPOPLITEAL BYPASS; FOLLOW UP; GRAFT PATENCY; HUMAN; LEG ISCHEMIA; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; POLITEF IMPLANT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCANDINAVIA;

AGED; ANASTOMOSIS, SURGICAL; ANTICOAGULANTS; BLOOD VESSEL PROSTHESIS; DRUG-ELUTING STENTS; FEMALE; FEMORAL ARTERY; FOLLOW-UP STUDIES; HEPARIN; HUMANS; MALE; PERIPHERAL ARTERIAL DISEASE; POLYTETRAFLUOROETHYLENE; POPLITEAL ARTERY; PROSTHESIS DESIGN; RETROSPECTIVE STUDIES; SCANDINAVIA; TREATMENT OUTCOME; ULTRASONOGRAPHY, DOPPLER, DUPLEX; VASCULAR PATENCY;

EID: 79954692714     PISSN: 10785884     EISSN: 15322165     Source Type: Journal    
DOI: 10.1016/j.ejvs.2011.01.021     Document Type: Article

References (8)

1. M. Dryjski, E. Mikat, and T.D. Bjornsson Inhibition of intimal hyperplasia after arterial injury by heparins and heparinoid J Vasc Surg 8 1988 623 633 (Pubitemid 19004056)
2. R.A. Edmondson, A.T. Cohen, S.K. Das, M.B. Wagner, and V.V. Kakkar Low-molecular weight heparin versus aspirin and dipyridamole after femoropopliteal bypass grafting Lancet 344 8927 1994 914 918 (Pubitemid 24295877)
3. C. Devine, B. Hons, and C. McCollum Heparin-bonded Dacron or polytetrafluoroethylene for femoropopliteal bypass grafting: a multicenter trial J Vasc Surg 2001 533 539 (Pubitemid 32215603)
4. P. Peeters, M. Boisers, J. Verbist, and K. Deloose Addressing early graft failure: mid term results with the Gore-Tex Propaten vascular graft J Endovasc Ther 11 2004 31
5. J.P. Eiberg, O. Røder, M. Stahl-Madsen, N. Eldrup, P. Qvarfordt, and A. Laursen Fluoropolymer-coated dacron versus PTFE grafts for femorofemoral cross-over bypass: randomised trial Eur J Vasc Endovasc Surg 32 2006 431 438 (Pubitemid 44362170)
6. F. Vermassen, and B. Jacobs All Belgian collaborators in the study. Late breaking RCT results: heparin-bonding PTFE in femoropopliteal bypass R. Greenhalgh, 31st symposium book - vascular and endovascular controversies update 2009 BIBA Publishing London, UK
7. P.C. Begovac, R.C. Thomson, J.L. Fisher, A. Hughson, and A. Gällhagen Improvements in GORE-TEX vascular graft performance by Carmeda BioActive surface heparin immobilization Eur J Vasc Endovasc Surg 25 2003 432 437 (Pubitemid 36603293)
8. G. Pedersen, E. Laxdal, V. Ellensen, T. Jonung, and E. Mattsson Improved patency and reduced intimal hyperplasia in PTFE grafts with luminal immobilized heparin compared with standard PTFE grafts at six months in a sheep model J Cardiovasc Surg 51 2010 443 448